Results 71 to 80 of about 15,297 (160)

Efficacy and safety of first-line oral vinorelbine plus firmonertinib in refractory <i>EGFR</i>-mutated non-small cell lung cancer: study protocol of a multicenter, non-randomized, two-cohort study. [PDF]

Ther Adv Med Oncol
Zhang B, Zhang Y, Shi C, Gao Z, Zhong R, Qiao R, Li S, Zhong H, Han B.   +8 more
europepmc   +1 more source

A real-world study of oral low-dose metronomic vinorelbine in elderly patients with metastatic triple-negative breast cancer. [PDF]

Sci Rep
Li J, Wang Y, Wang Q, Zhang L, Li H, Li W, Yao L.   +6 more
europepmc   +1 more source

Metronomic chemotherapy combined with immunotherapy in solid tumor: a systematic review. [PDF]

Transl Cancer Res
Li S, Li Z, Liu X, Yu H.
europepmc   +1 more source

Vinorelbine [PDF]

Reactions Weekly, 2020
  +4 more sources

Perforated acalculous cholecystitis in a neutropenic patient following chemotherapy: a fatal case report. [PDF]

J Surg Case Rep
Deng YJ.
europepmc   +1 more source

Hypertrophic Osteopathy Associated With Primary Pulmonary Histiocytic Sarcoma in a Dog. [PDF]

Vet Med Sci
Rinaldi V, Ridolfi F, Finotello R, Rosto M, Luciani A, Boari A, Crisi PE.   +6 more
europepmc   +1 more source

A phase 1b open-label, dose-escalating study of safety and efficacy of disulfiram, copper and vinorelbine in advanced solid tumors. [PDF]

BMC Cancer
Eefsen RL, Stenvang J, Bartek J, Pfeiffer P, Tarpgaard L, Theile S, Brünner N, Nielsen DL.   +7 more
europepmc   +1 more source

A Computational Investigation of the ¹⁵N Chemical Shift Behavior of <i>Strychnos</i> Alkaloids. [PDF]

Int J Mol Sci
Semenov VA, Krivdin LB, Martin GE.
europepmc   +1 more source

Surface-engineered dual drug-loaded tumor-targeted liposomal nanoparticles to overcome the therapeutic resistance in glioblastoma multiforme. [PDF]

Commun Med (Lond)
Angom RS, Rachamala HK, Nakka NMR, Madamsetty VS, Suarez-Meade P, Fernandez-Gil BI, Kulkarni T, Weil RM, Dutta S, Wang E, Bhattacharya S, Pal K, Quinones-Hinojosa A, Mukhopadhyay D.   +13 more
europepmc   +1 more source

Model-Based Meta-Analysis of Overall Survival in Vulnerable Platinum-Ineligible NSCLC Populations. [PDF]

CPT Pharmacometrics Syst Pharmacol
Chen J, Wada R, Zhang N, Graupner V, Morris S, Hu Y, Zhang W, Kassir N, Wu B, Chan P.   +9 more
europepmc   +1 more source